| Electroencephalogram Predicts Post-operative Delirium (NCT06894238) | Beijing Sanbo Brain Hospital | 2025-03-01 |
| Mechanical Ventilation on Hippocampus (NCT06480162) | Beijing Sanbo Brain Hospital | 2024-05-08 |
| M-I/E for Preventing VAP in Post-neurosurgical Patients (NCT06511986) | Beijing Sanbo Brain Hospital | 2024-03-04 |
| Intraoperative Diaphragmatic Neuromodulation (NCT06518707) | Beijing Sanbo Brain Hospital | 2024-02-26 |
| Post-neurosurgical Respiratory Muscle Dysfunction (NCT05951114) | Beijing Sanbo Brain Hospital | 2023-07-01 |
| Retrospective Study of Germ Cell Tumors of the Central Nervous System (NCT05836701) | Beijing Sanbo Brain Hospital | 2023-06-01 |
| Modified CV Regimen in Optic Pathway Glioma (NCT05278715) | Beijing Sanbo Brain Hospital | 2022-04-13 |
| Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM) (NCT04952571) | Beijing Sanbo Brain Hospital | 2021-06-27 |
| Glioblastoma Response Prediction to Apatinib (NCT04814329) | Beijing Sanbo Brain Hospital | 2021-04-22 |
| Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas (NCT04659421) | Beijing Sanbo Brain Hospital | 2020-11-03 |
| Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children (NCT04501718) | Beijing Sanbo Brain Hospital | 2020-10-28 |
| Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults (NCT04501705) | Beijing Sanbo Brain Hospital | 2020-08-18 |
| Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) (NCT04070040) | Beijing Sanbo Brain Hospital | 2020-02-13 |
| Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas (NCT04267978) | Beijing Sanbo Brain Hospital | 2020-02-13 |